Directory › Catalent
Catalent — Beinheim
Beinheim, France · CDMO
Site facts
- Company
- Catalent
- Name(s) in FDA data
- Catalent France Beinheim SA
- FEI number(s)
- 3002808036 (present in FDA Data Dashboard records for this name and city)
- Location (as in FDA data)
- Beinheim, France
- Records matched
- 6 FDA inspections
- Most recent FDA inspection in dataset
- 25 Nov 2022 — VAI
Capabilities (from the company's website)
- Small molecule
…products. Contact Us About This Site View Job Openings Facility at a Glance Service Area Small Molecule Facility Type Discovery Development Manufacturing Commercialization Innovation Certificat…
- Highly potent (HPAPI)
…a wide range of product types, from hormones and controlled substances to cytostatics and highly potent compounds, the site supports both innovative and generic programs across the full develop…
- Oral solid dose
…oduct Launches Small Molecule Commercialization Softgel Commercial CGMP Manufacturing for Oral Solid & Liquid Tech Transfers & Product Launches Location & Contact Address 74, Rue principale…
- Softgels
…ce Beinheim is Catalent’s European Center of Excellence for lipid‑based drug delivery and softgel development, providing advanced formulation and large‑scale manufacturing capabilities fo…
- Clinical trial supply & packaging
…ea OTC Dietary Supplements Skin, Hair & Fragrance Facility Type Development Manufacturing Packaging Commercialization Innovation Certifications Highlights FDA AIFA TGA China Russia MOH HALA…
- Analytical testing
…bring therapies to the clinic more quickly. Its integrated capabilities span formulation, analytical development, and manufacturing, providing customers with a comprehensive solution under one roof. Thi…
- Controlled substances
…e challenges. With the ability to handle a wide range of product types, from hormones and controlled substances to cytostatics and highly potent compounds, the site supports both innovative and generi…
Taken from the company's web page for this site. Source: https://www.catalent.com/locations/beinheim-france, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.
Regulatory timeline
Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.
-
25 Nov 2022FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 1302124)
-
29 Oct 2020FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 1174733)
-
21 Jul 2017FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 1022739)
-
20 Mar 2014FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 878382)
-
13 Jul 2012FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 792665)
-
17 Sep 2009FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002808036, inspection ID 621606)
This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.